Disease_category,Disease,Protein,Protein_definition,Method,Nb_SNP,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.95 [0.90-1.00],0.0586364339658472
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,15,0.98 [0.90-1.07],0.611806235516854
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,34,1.17 [1.02-1.33],0.0216545059064229
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,23,0.99 [0.85-1.15],0.87319071847883
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FSTL3,Follistatin-related protein 3,Inverse variance weighted,7,0.89 [0.76-1.04],0.14602163438357
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SHISA5,Protein shisa-5,Inverse variance weighted,16,0.93 [0.79-1.09],0.366862149581961
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.08 [0.79-1.47],0.640415608724735
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,40,1.06 [0.98-1.15],0.151418928144626
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,5,0.81 [0.56-1.17],0.255972648145211
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.90 [0.77-1.06],0.213835949463488
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TFF3,Trefoil factor 3,Inverse variance weighted,10,0.90 [0.80-1.02],0.10899858839674
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,15,0.98 [0.90-1.06],0.561561638148434
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",OCLN,Occludin,Inverse variance weighted,3,0.93 [0.77-1.12],0.424136096072571
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1.15 [1.03-1.29],0.0141458461136215
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.99 [0.84-1.17],0.911881052636474
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.91 [0.71-1.17],0.461012640955687
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EGFR,Epidermal growth factor receptor,Inverse variance weighted,15,1.03 [0.87-1.21],0.756085623132835
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,20,0.98 [0.89-1.07],0.630147359934284
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,17,1.42 [0.99-2.02],0.0539877333337247
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,15,1.07 [0.94-1.22],0.301844602811752
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,41,1.09 [1.03-1.16],0.004704984072626
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,18,1.05 [0.97-1.14],0.187257725003306
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ANGPT2,Angiopoietin-2,Inverse variance weighted,11,1.11 [0.97-1.27],0.137220562780897
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,5,1.18 [0.92-1.52],0.190049476635662
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CST3,Cystatin-C,Inverse variance weighted,13,1.03 [0.96-1.12],0.410877337389
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.96 [0.87-1.06],0.405720498582882
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,8,1.13 [0.88-1.44],0.341083780118588
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,32,1.00 [0.97-1.04],0.767661500613372
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,31,1.02 [0.95-1.09],0.665016561319371
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CTSO,Cathepsin O,Inverse variance weighted,22,0.89 [0.73-1.09],0.266428243860466
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",RBP5,Retinol-binding protein 5,Inverse variance weighted,5,1.14 [0.89-1.46],0.296964569870126
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LGALS4,Galectin-4,Inverse variance weighted,19,0.91 [0.84-0.98],0.0104505428786769
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",AGRN,Agrin,Inverse variance weighted,31,1.01 [0.95-1.09],0.699587664217513
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.98 [0.91-1.06],0.671217458532593
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,23,0.96 [0.88-1.05],0.35190680130239
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SCARB2,Lysosome membrane protein 2,Inverse variance weighted,17,1.06 [0.95-1.18],0.315727000776877
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.02 [0.80-1.32],0.849087906446545
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,4,0.93 [0.78-1.10],0.398069047251485
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",APOC1,Apolipoprotein C-I,Inverse variance weighted,18,1.01 [0.83-1.22],0.953880840206113
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GAST,Gastrin,Inverse variance weighted,9,0.92 [0.80-1.07],0.284797012542098
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,15,1.03 [0.87-1.23],0.701688046760281
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CD276,CD276 antigen,Inverse variance weighted,47,0.98 [0.94-1.02],0.380329515422506
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FAM3C,Protein FAM3C,Inverse variance weighted,5,1.15 [0.91-1.46],0.249525527734261
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TFF2,Trefoil factor 2,Inverse variance weighted,16,0.98 [0.83-1.15],0.791253593454584
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,17,1.04 [0.96-1.12],0.37029413199418
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ADM,Pro-adrenomedullin,Inverse variance weighted,4,0.91 [0.80-1.04],0.1567658669097
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.86 [0.75-0.99],0.0338617130541571
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PLTP,Phospholipid transfer protein,Inverse variance weighted,30,1.00 [0.94-1.07],0.987331800474693
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.18 [0.93-1.49],0.174370298408699
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",VWC2,Brorin,Inverse variance weighted,35,1.05 [0.99-1.11],0.100744822831206
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",RTN4R,Reticulon-4 receptor,Inverse variance weighted,26,1.03 [0.95-1.11],0.475649571995565
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,17,0.94 [0.82-1.07],0.34888572041806
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,17,1.04 [0.97-1.11],0.312727483530173
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",APCS,Serum amyloid P-component,Inverse variance weighted,7,0.98 [0.88-1.10],0.742486965852903
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",MENT,Protein MENT,Inverse variance weighted,30,1.11 [0.99-1.24],0.087628157688838
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.89 [0.77-1.02],0.100340164318704
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CFD,Complement factor D,Inverse variance weighted,12,0.97 [0.86-1.08],0.54899158115972
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.15 [0.67-1.99],0.613465780551405
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.10 [1.00-1.22],0.0572158527328508
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.11 [1.02-1.21],0.021162837047222
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,13,0.94 [0.84-1.06],0.330713566724955
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,10,1.24 [1.06-1.46],0.0069796809500047
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.96 [0.77-1.19],0.705219965045898
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",REG1A,Lithostathine-1-alpha,Inverse variance weighted,26,0.99 [0.93-1.05],0.754616833588099
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,31,0.98 [0.87-1.11],0.733920897037048
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CD300E,CMRF35-like molecule 2,Inverse variance weighted,36,0.96 [0.91-1.02],0.168201501649775
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,15,0.98 [0.89-1.09],0.743750129645205
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,21,1.76 [1.29-2.40],0.0003610350778952
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PSAP,Prosaposin,Inverse variance weighted,13,1.03 [0.92-1.17],0.5864546764053
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",COLEC12,Collectin-12,Inverse variance weighted,13,0.93 [0.82-1.07],0.321102346875062
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",MMP12,Macrophage metalloelastase,Inverse variance weighted,21,1.00 [0.96-1.04],0.97128934577087
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,30,1.04 [0.96-1.11],0.334821228077252
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,16,1.00 [0.95-1.06],0.913967421967062
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EFNA4,Ephrin-A4,Inverse variance weighted,5,1.09 [0.90-1.33],0.373255042056567
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PGF,Placenta growth factor,Inverse variance weighted,8,1.09 [0.86-1.38],0.480626461139572
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SPON1,Spondin-1,Inverse variance weighted,25,1.02 [0.95-1.09],0.619219738688785
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.02 [0.89-1.17],0.755988937750984
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",REN,Renin,Inverse variance weighted,12,1.02 [0.94-1.11],0.616860264431852
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.93 [0.83-1.05],0.244586835114565
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GUCA2A,Guanylin,Inverse variance weighted,16,0.99 [0.90-1.09],0.877497903809238
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",HYAL1,Hyaluronidase-1,Inverse variance weighted,23,1.07 [0.99-1.16],0.0947255564348384
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",HGF,Hepatocyte growth factor,Inverse variance weighted,7,1.11 [0.92-1.34],0.273914631214427
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CD302,CD302 antigen,Inverse variance weighted,17,0.95 [0.88-1.03],0.203932239169867
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",REG1B,Lithostathine-1-beta,Inverse variance weighted,26,1.00 [0.95-1.06],0.923093515190689
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,13,1.53 [1.34-1.75],3.92207695679362e-10
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,29,0.95 [0.91-1.00],0.0674728179888053
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LGALS9,Galectin-9,Inverse variance weighted,39,0.97 [0.92-1.02],0.2738711758749
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ANXA10,Annexin A10,Wald ratio,1,0.93 [0.55-1.56],0.779273193985051
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,8,0.91 [0.70-1.18],0.477375343692635
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PGA4,Pepsin A-4,Inverse variance weighted,9,0.91 [0.74-1.11],0.352575242113473
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LAYN,Layilin,Inverse variance weighted,23,0.99 [0.92-1.07],0.811301292077981
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,14,0.94 [0.83-1.06],0.337291665125345
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",AREG,Amphiregulin,Inverse variance weighted,7,0.89 [0.77-1.03],0.123429939680403
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",C7,Complement component C7,Inverse variance weighted,60,1.01 [0.98-1.04],0.542284742682733
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FGF23,Fibroblast growth factor 23,Inverse variance weighted,17,1.14 [0.96-1.35],0.1243855875633
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EDN1,Endothelin-1,Inverse variance weighted,3,0.94 [0.83-1.06],0.293637801480958
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CD83,CD83 antigen,Inverse variance weighted,19,0.99 [0.88-1.11],0.847719035929169
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",REG4,Regenerating islet-derived protein 4,Inverse variance weighted,19,0.96 [0.78-1.19],0.718643383049486
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",AOC3,Membrane primary amine oxidase,Inverse variance weighted,35,1.01 [0.96-1.06],0.704746124938127
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",UMOD,Uromodulin,Inverse variance weighted,62,1.01 [0.97-1.05],0.653852495190557
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PRSS8,Prostasin,Inverse variance weighted,19,1.03 [0.93-1.15],0.535832292010596
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,18,0.98 [0.87-1.11],0.777763856911193
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.94 [0.75-1.17],0.560144262224265
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,28,0.99 [0.95-1.04],0.781312908837047
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",AMBP,Protein AMBP,Inverse variance weighted,5,1.16 [0.87-1.55],0.30221231498809
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",OGN,Mimecan,Inverse variance weighted,37,0.99 [0.94-1.05],0.813399592852074
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,6,0.84 [0.76-0.94],0.0014257384924162
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",RNASE1,Ribonuclease pancreatic,Inverse variance weighted,6,0.99 [0.88-1.10],0.791253133700529
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,23,0.92 [0.85-1.00],0.0460179996503075
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",MMP7,Matrilysin,Inverse variance weighted,15,1.01 [0.94-1.09],0.74004177902957
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TFF1,Trefoil factor 1,Inverse variance weighted,14,1.04 [0.96-1.12],0.374499923621344
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,5,1.05 [0.70-1.57],0.813438369672224
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",F7,Coagulation factor VII,Inverse variance weighted,30,1.04 [0.97-1.11],0.241282849955548
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",MFGE8,Lactadherin,Inverse variance weighted,26,1.11 [1.00-1.24],0.0495128943663805
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,30,0.93 [0.87-0.99],0.0243135170751255
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SPON2,Spondin-2,Inverse variance weighted,8,0.91 [0.83-1.01],0.0713550003642802
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.91 [0.24-3.44],0.891187100883794
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EPO,Erythropoietin,Inverse variance weighted,14,1.01 [0.88-1.15],0.901752227668971
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,19,0.99 [0.93-1.05],0.74081857927028
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.98 [0.89-1.07],0.586806881657796
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",LGALS3,Galectin-3,Inverse variance weighted,42,1.00 [0.95-1.05],0.926996037151201
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CHGA,Chromogranin-A,Inverse variance weighted,8,1.00 [0.90-1.12],0.988718686088634
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",RNASE4,Ribonuclease 4,Inverse variance weighted,13,0.97 [0.88-1.08],0.61177202561664
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.96 [0.84-1.10],0.529334958306273
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PALM2,Paralemmin-2,Inverse variance weighted,9,1.10 [0.99-1.22],0.072019053195145
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,50,1.09 [1.02-1.17],0.0145083127054925
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,11,0.99 [0.89-1.10],0.846635824201091
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",POF1B,Protein POF1B,Inverse variance weighted,4,1.05 [0.83-1.32],0.698115622586092
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FGL1,Fibrinogen-like protein 1,Inverse variance weighted,38,0.98 [0.93-1.04],0.521385010946702
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IL12A_IL12B,Interleukin-12,Inverse variance weighted,57,0.97 [0.93-1.02],0.217195868807441
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",SCG2,Secretogranin-2,Inverse variance weighted,3,1.03 [0.48-2.21],0.949711425819944
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,9,0.90 [0.74-1.09],0.267118381224972
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.05 [0.87-1.27],0.603663583930602
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FAM3B,Protein FAM3B,Inverse variance weighted,26,0.98 [0.93-1.03],0.4194907951095
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,10,0.94 [0.78-1.12],0.476194651004264
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.05 [0.94-1.18],0.357292972582751
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NFASC,Neurofascin,Inverse variance weighted,19,0.90 [0.84-0.97],0.004748963330279
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",IL12B,Interleukin-12 subunit beta,Inverse variance weighted,63,0.99 [0.95-1.03],0.508568769109457
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,15,0.92 [0.84-1.00],0.0626520358455398
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CTSS,Cathepsin S,Inverse variance weighted,30,1.03 [0.97-1.09],0.321223463685642
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.00 [0.97-1.04],0.938544184935818
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.02 [0.83-1.25],0.868075979371059
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",ELN,Elastin,Inverse variance weighted,12,1.12 [0.80-1.57],0.514084080897359
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CTSB,Cathepsin B,Inverse variance weighted,50,1.03 [0.98-1.08],0.280143876823636
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,5,0.95 [0.76-1.18],0.623753093825
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,13,1.03 [0.99-1.07],0.16142161370713
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",NTRK3,NT-3 growth factor receptor,Inverse variance weighted,15,0.95 [0.86-1.05],0.314370514748151
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",RNASE6,Ribonuclease K6,Inverse variance weighted,20,0.98 [0.92-1.05],0.589827566458555
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",CPM,Carboxypeptidase M,Inverse variance weighted,23,1.14 [1.00-1.28],0.0428034529793395
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",PENK,Proenkephalin-A,Inverse variance weighted,21,1.04 [0.97-1.11],0.31733878481681
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,19,1.02 [0.96-1.08],0.546858309990149
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GDF15,Growth/differentiation factor 15,Inverse variance weighted,14,0.98 [0.85-1.12],0.724520878899937
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,46,1.01 [0.96-1.07],0.619508466503971
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,1.01 [0.81-1.27],0.910548163398844
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,18,0.94 [0.88-1.01],0.105932999438566
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",EFNA1,Ephrin-A1,Inverse variance weighted,15,0.98 [0.89-1.09],0.757209842920091
"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",GPR37,Prosaposin receptor GPR37,Inverse variance weighted,62,1.00 [0.94-1.06],0.922027920395847
